Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 09969 INNOCARE-B > Detailed Quotes

09969 INNOCARE-B

7.960
-0.210-2.57%
Closed 09/30 16:08 CCT
High
8.210
Open
8.210
Turnover
8.27M
Low
7.860
Pre Close
8.170
Volume
1.04M
Market Cap
14.04B
P/E(TTM)
Loss
52wk High
22.300
Shares
1.76B
P/E(Static)
Loss
52wk Low
7.860
Float Cap
11.94B
Bid/Ask %
-8.00%
Historical High
32.050
Shs Float
1.50B
Volume Ratio
0.47
Historical Low
7.860
Dividend TTM
--
Div Yield TTM
--
P/B
2.20
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.07%
Amplitude
4.28%
Avg Price
7.948
Lot Size
1000
Float Cap
11.94B
Bid/Ask %
-8.00%
Historical High
32.050
Shs Float
1.50B
Volume Ratio
0.47
Historical Low
7.860
Dividend TTM
--
P/B
2.20
Dividend LFY
--
Turnover Ratio
0.07%
Amplitude
4.28%
Avg Price
7.948
Lot Size
1000
Price Forecast

No Data

News

Comment

Company Overview More
Nuocheng Jianhua Pharmaceutical Co., Ltd. is a Chinese company mainly engaged in biomedical research, production and commercialization. The company focuses on areas where there are huge unmet clinical needs, such as oncology and autoimmune diseases. The company's main product lines include Obutinib, Ibutini, Zebutini, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723 and ICP-189. Its products are mainly used in the treatment of hematoma, solid tumor and autoimmune disease. The company is also developing products for the treatment of autoimmune diseases caused by B or T cell dysfunction. The company mainly operates in domestic and foreign markets.
CEO: Jisong Cui
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...